Odyssey Health Income Statement (2014-2026) | ODYY

Income Statement Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Revenue & cost
Revenue (Quarter)
Cost of Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)
1.02M0.32M0.46M0.06M0.47M0.35M0.17M0.04M0.02M0.04M-0.01M
Selling, General & Administrative (Quarter)
1.11M1.52M2.80M-2.51M0.43M0.65M0.51M0.02M0.50M0.44M0.32M0.82M0.58M0.16M0.13M0.16M0.30M0.18M0.30M
Other Operating Expenses (Quarter)
-49.000.50M15.90M
Operating Expenses (Quarter)
1.02M1.43M1.98M2.87M-2.04M0.79M0.82M0.54M0.02M0.52M0.48M0.32M0.81M0.58M0.16M0.13M0.16M0.30M0.18M0.30M
Operating Income (Quarter)
-2.61M-1.43M-1.98M-2.87M-1.83M-2.08M-1.49M-1.09M-0.66M-0.35M-1.16M-0.37M0.24M-0.58M-0.16M-0.13M-0.16M-0.30M-0.18M-0.30M
EBIT (Quarter)
-2.61M-1.43M-1.98M-2.87M-1.83M-2.08M-1.49M-1.09M-0.66M-0.35M-1.16M-0.37M0.24M-0.58M-0.16M-0.13M-0.16M-0.30M-0.18M-0.30M
Non-operating items
Non Operating Investment Income (Quarter)
-1.33M-0.37M0.06M-0.37M-0.06M-0.03M
Other Non Operating Income (Quarter)
0.49M-474.000.01M-79.00275.0065.000.01M186.00121.00-0.01M28.00-0.01M45.00
Non Operating Income (Quarter)
-474.000.01M-79.00275.0065.000.01M186.00121.00-102.0064.00-0.01M28.00-0.01M45.00
Net income details
EBT (Quarter)
-2.90M-1.65M-2.18M-3.10M-2.01M-2.15M-1.68M-1.28M-0.81M-0.54M-1.30M-0.47M0.15M-0.65M-0.22M-0.19M-0.21M-0.40M-0.59M-0.83M
Profit After Tax (Quarter)
-2.90M-1.65M-1.69M-3.10M-2.01M-2.15M-1.67M-1.28M-0.81M-0.54M13.28M-0.84M-12.74M-1.02M-0.22M-0.25M-0.25M-0.48M-3.60M0.77M
Income from Continuing Operations (Quarter)
-2.90M-1.65M-2.18M-3.10M-2.01M-2.15M-1.68M-1.28M-0.81M-0.54M-1.30M-0.47M0.15M-0.65M-0.22M-0.19M-0.21M-0.40M-0.59M-0.83M
Consolidated Net Income (Quarter)
-2.90M-1.65M-2.18M-3.10M-2.01M-2.15M-1.68M-1.28M-0.81M-0.54M-1.30M-0.47M0.15M-0.65M-0.22M-0.19M-0.21M-0.40M-0.59M-0.83M
Income towards Parent Company (Quarter)
-2.90M-1.65M-2.18M-3.10M-2.01M-2.15M-1.68M-1.28M-0.81M-0.54M-1.30M-0.47M0.15M-0.65M-0.22M-0.19M-0.21M-0.40M-0.59M-0.83M
Net Income towards Common Stockholders (Quarter)
-2.90M-1.65M-2.18M-3.10M-2.01M-2.15M-1.67M-1.28M-0.81M-0.54M13.21M-0.84M-12.74M-0.65M-0.22M-0.25M-0.25M-0.40M-0.59M1.24M
Additional items
EPS (Basic) (Quarter)
-0.03-0.02-0.02-0.04-0.02-0.03-0.02-0.02-0.01-0.010.14-0.01-0.14-0.010.000.00-0.010.00-0.030.01
EPS (Weighted Average and Diluted) (Quarter)
-0.03-0.02-0.02-0.04-0.02-0.03-0.02-0.02-0.01-0.010.12-0.01-0.12-0.010.000.00-0.010.00-0.030.01
Shares Outstanding (Weighted Average) (Quarter)
93.73M88.06M91.62M83.95M89.00M80.89M81.62M83.16M14.56M81.00M89.88M94.50M97.06M104.71M104.71M104.71M21.48M106.04M1.54M108.03M
Shares Outstanding (Diluted Average) (Quarter)
93.73M88.06M91.62M88.84M89.00M80.89M81.78M83.16M82.68M81.02M114.06M113.90M97.06M104.71M104.71M104.71M104.71M106.04M107.85M107.30M
EBITDA (Quarter)
-2.61M-1.43M-1.98M-2.87M-1.83M-2.08M-1.49M-1.09M-0.66M-0.35M-1.16M-0.37M0.24M-0.58M-0.16M-0.13M-0.16M-0.30M-0.18M-0.30M
Interest Expenses (Quarter)
0.29M0.22M0.21M0.23M0.18M0.07M0.19M0.19M0.16M0.19M0.14M0.10M0.08M0.07M0.06M0.06M0.06M0.10M0.41M0.53M